https://doi.org/10.1016/s0140-6736(10)61121-x
J
Josef Rüschoff
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
338
Papers
29.3K
Citations
60
h-index
167
i10-index
Josef Rüschoff is an academic researcher from University of Kassel. The author has contributed to research in topics: Genetic factors in colorectal cancer & HER2/EGFR in Cancer Research & Cancer Genomics and Diagnostics. The author has an h-index of 60, co-authored 288 publications.
ORCID: 0000-0003-1467-8149Papers by this author
worksTrastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 · The Lancet · 7,196 citations
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
2005 · New England Journal of Medicine · 5,074 citations
https://doi.org/10.1056/nejmoa052306
Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability
2004 · JNCI Journal of the National Cancer Institute · 3,161 citations
https://doi.org/10.1093/jnci/djh034
Assessment of a HER2 scoring system for gastric cancer: results from a validation study
2008 · Histopathology · 1,180 citations
https://doi.org/10.1111/j.1365-2559.2008.03028.x
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
2014 · Gastric Cancer · 592 citations
https://doi.org/10.1007/s10120-014-0402-y
HER2 testing in gastric cancer: a practical approach
2012 · Modern Pathology · 586 citations
https://doi.org/10.1038/modpathol.2011.198
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat